Adaptive Biotechnologies sees stock surge after clonoSEQ EU certification
In a major development for the biotechnology sector, Adaptive Biotechnologies Corporation witnessed a remarkable 29% surge in its stock value following a key regulatory milestone. The company announced that its flagship product, the clonoSEQ Assay, has secured In Vitro Diagnostic Regulation (IVDR) certification in the European Union, making it the first and only test approved […]